Probiotic Research
· RCT
An AI classifier placed this paper in one study type. Classification is audited, but an individual label can still be wrong — read the source before leaning on it.
How we classify this →
Save
Evaluation of the Efficacy of Combined Therapy with Rifaximin and Saccharomyces boulardii CNCM I-745 in Patients with Small Intestinal Bacterial Overgrowth during Long-Term Proton Pump Inhibitor Use
Изучение эффективности комбинированной терапии с применением рифаксимина и Saccharomyces boulardii CNCM I-745 у пациентов с синдромом избыточного бактериального роста в тонкой кишке на фоне длительного приема ингибиторов протонной помпы
· CyberLeninK (CyberLeninka)
· View source →
AI-generated summary of what this paper reports
Russian prospective RCT evaluated rifaximin plus S. boulardii CNCM I-745 versus rifaximin monotherapy in patients with PPI-associated SIBO. The combination showed improved eradication rates and symptom resolution.
Linked strains How central each strain is to this paper: a main subject, one of several organisms studied, or a passing mention. How we classify this →
Discussion
Be the first to comment.
Sign in to join the discussion.
No comments yet.